Search Results For ''

  • Bubs Australia founder and CEO forced out for alleged failure to comply with board directions

    Just a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business, the baby milk formula company announced another shake up of its executive line up. Perhaps a foreseeable one, this time founder and CEO Kristy Carr was terminated from her position with immediate effect due to

    Read More
    Public
  • Appen share price falls over 20% after disappointing April update

    Machine intelligence company Appen (ASX: APX) must be having Covid flashbacks as its share price is tanking once again. Once an ASX dreamboat, falling demand for the Company’s products has left it to take on cost reduction initiatives. In February 2023, in its annual report, Appen stated that it expects a soft start to FY23

    Read More
    Public
  • The Redbubble bubble bursts with mass layoffs underlining the quarter

    Over the past year, tech companies in the US have become notorious for mass layoffs. IT giants, from Google to Amazon, have laid off thousands of employees in light of growing inflation. Now, that trend seems to be gaining steam in Australia.  To return to cash flow positivity, Aussie online print-on-demand marketplace Redbubble (ASX: RBL)

    Read More
    Public
  • Shares continue to tread water as they wait on data

    The XJO is expected to edge lower on open this morning following a similar move from the U.S last night and their flat futures this morning. Markets are simply quiet heading into the CPI reading tonight in the U.S. Locally, we had the federal budget released last night. We don’t see this affecting our market

    Read More
    Public
  • Proteomics’ PromarkerD test enters the lucrative US market

    Successful early diagnosis of diabetic kidney disease (DKD) delivers a win-win-win situation for the medical professionals who treat this disease, its sufferers and the cost base of any country’s health system. Doctors would gain access to speedier diagnosis, opening the way for them to deliver more efficacious treatment decisions that improve clinical outcomes for patients,

    Read More
    Public
  • Drug that stops growth of cancerous cells shows positive results

    12-year-old Louie the beagle had little time left once the vet diagnosed his lymphoma. To avoid the side effects of steroids and chemo, his parents took a chance on biotech company PharmAust’s (ASX: PAA) monepantel (MPL) drug. Within a few weeks, Louie’s lymph nodes shrunk and he enjoyed a good quality of life. Today, he

    Read More
    Public